Roche Holding Ltd insider trades: Jasper Therapeutics (JSPR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Roche Holding Ltd reports to the SEC
and 1 more company
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 25, 2023 | JSPR | ↓ Sell | 75,000 | $1.89 | $142K | Indirect | Jan 26, 2023 (1d) |
| Jul 21, 2020 | PAND | ↑ Buy | 36,111 | $18.00 | $650K | Indirect | Jul 23, 2020 (2d) |
| Jul 31, 2018 | FMI | ↑ Buy | 16,221,027 | $137.00 | $2.22B | Direct | Aug 2, 2018 (2d) |
| Jul 5, 2017 | ALRN | ↑ Buy | 119,400 | $15.00 | $1.8M | Direct | Jul 5, 2017 (0d) |
| Apr 7, 2015 | FMI | ↑ Buy | 15,604,288 | $50.00 | $780.2M | Direct | Apr 9, 2015 (2d) |
| Jun 26, 2007 | BIOV | ↑ Buy | 1,000 | $21.50 | $22K | Direct | Jul 6, 2007 (10d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Roche Holding Ltd's insider trades
Roche Holding Ltd is a 10% owner of Jasper Therapeutics (JSPR). Since Jun 26, 2007, it has reported 5 open-market purchases worth $3.00B and 1 sale worth $142K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (4 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JSPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.